About
Astellas Venture Management (AVM) is the wholly-owned venture capital organization within Astellas Pharma Inc., a global pharmaceutical company headquartered in Tokyo, Japan. AVM is dedicated to supporting pre-clinical, cutting-edge science that can bring value to patients. For over 20 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research. The firm focuses on innovative therapeutic approaches aligned with Astellas Pharma's R&D strategy, prioritizing companies with programs and technologies that fulfill unmet medical needs. AVM provides portfolio companies with R&D advice and assistance, leveraging its pharmaceutical industry expertise and facilitating dialogue for future collaborations with Astellas Pharma.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Astellas Venture Management's primary investment focus?
- Astellas Venture Management is a HealthTech VC that invests in early-stage companies developing therapeutic programs and platform technologies.
- What is a recent investment made by Astellas Venture Management?
- In September 2024, Astellas Venture Management participated in a Seed round for Somite.ai, an AI-based platform producing human tissue for cell-based therapies. The company raised $57.5M in this round.
- Which sectors does Astellas Venture Management primarily invest in?
- Astellas Venture Management focuses on the Health Tech & Life Sciences sector, with all its recorded investments and portfolio companies falling within this category.
- What is Astellas Venture Management's typical investment stage?
- Astellas Venture Management primarily invests in Seed stage companies, as evidenced by their investment in Somite.ai.
- Can you name a notable company in Astellas Venture Management's portfolio?
- Somite.ai, an AI-based platform for producing human tissue for cell-based therapies, is a notable company in Astellas Venture Management's portfolio.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | astellasventure.com/ |
|---|
Identifiers & details
| Founded | 2005 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | astellasventure.com |
|---|